Skip to main content
Erschienen in: The International Journal of Cardiovascular Imaging 11/2022

04.07.2022 | Original Paper

Prevalence and factors associated with impaired left ventricular global longitudinal strain in patients with Chagas disease: SaMi-Trop cohort study

verfasst von: Omar Ribeiro Santos Junior, Ester Cerdeira Sabino, Vinícius Tostes Carvalho, Bruno Oliveira de Figueiredo Brito, Lea Campos de Oliveira, Ariela Mota Ferreira, Marcelo Alves Maia, Nayana Flamini Arantes Gomes, Antonio Luiz P. Ribeiro, Maria Carmo P. Nunes

Erschienen in: The International Journal of Cardiovascular Imaging | Ausgabe 11/2022

Einloggen, um Zugang zu erhalten

Abstract

Cardiomyopathy is a major cause of death in Chagas disease and early detection of cardiac involvement is essential. Myocardial strain is a reliable technique for assessment of subtle left ventricular (LV) contractility alterations. This study assessed LV global longitudinal strain (GLS) in a large Chagas disease population living in remote areas. Between 2015 and 2016, Chagas disease patients were selected in the northern of the Minas Gerais state. All patients underwent T. cruzi antibodies tests and those who had positive tests were included. A resting 12-lead ECG was recorded and classified using the Minnesota Code criteria. Echocardiography was performed at public health primary care units and speckle-tracking strain was analyzed offline. LV dysfunction was defined as ejection fraction (LVEF < 50%) and reduced GLS was defined as < 16% (absolute value). A total of 1387 patients were included, mean age of 60.0 ± 12.5 years, 68% were women, and 14% had LV dysfunction. Among patients with normal LVEF, 59% had impaired LV GLS. Overall, patients with impaired GLS were older, had more comorbidities and ECG abnormalities than those with normal GLS. The independent factors associated with reduced GLS were ST-T abnormalities (OR 1.954; 95% CI 1.027–3.718), QRS duration (OR 1.009; 95% CI 1.002–1.016), LVEF (OR 0.947; 95% CI 0.923–0.972), and E/e’ ratio (OR 1.059; 95% CI 1.009–1.112). In a cohort of Chagas disease from endemic areas, impaired LV GLS was detected in a significant proportion of patients, despite normal ECG and preserved LVEF. The main determinants of reduced LV GLS were ST-T abnormalities, QRS duration, LVEF and E/e' ratio, adjusting for demographical and clinical data.
Literatur
1.
Zurück zum Zitat WHO/PAHO (2016) Neglected infectious diseases in the Americas: success stories and innovation to reach the neediest. WHO, Geneva WHO/PAHO (2016) Neglected infectious diseases in the Americas: success stories and innovation to reach the neediest. WHO, Geneva
2.
Zurück zum Zitat World Health Organization (2015) Chagas disease in latin America: an epidemiological update based on 2010 estimates. Wkl Epidemiol Rec 90:33–44 World Health Organization (2015) Chagas disease in latin America: an epidemiological update based on 2010 estimates. Wkl Epidemiol Rec 90:33–44
5.
Zurück zum Zitat Marin-Neto JA, Cunha-Neto E, Maciel BC, Simoes MV (2007) Pathogenesis of chronic Chagas heart disease. Circulation 115:1109–1123CrossRefPubMed Marin-Neto JA, Cunha-Neto E, Maciel BC, Simoes MV (2007) Pathogenesis of chronic Chagas heart disease. Circulation 115:1109–1123CrossRefPubMed
6.
Zurück zum Zitat Ribeiro AL, Sabino EC, Marcolino MS et al (2013) Electrocardiographic abnormalities in trypanosoma cruzi seropositive and seronegative former blood donors. PLoS Negl Trop Dis 7:e2078CrossRefPubMedPubMedCentral Ribeiro AL, Sabino EC, Marcolino MS et al (2013) Electrocardiographic abnormalities in trypanosoma cruzi seropositive and seronegative former blood donors. PLoS Negl Trop Dis 7:e2078CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Sabino EC, Ribeiro AL, Salemi VM et al (2013) Ten-year incidence of Chagas cardiomyopathy among asymptomatic trypanosoma cruzi-seropositive former blood donors. Circulation 127:1105–1115CrossRefPubMedPubMedCentral Sabino EC, Ribeiro AL, Salemi VM et al (2013) Ten-year incidence of Chagas cardiomyopathy among asymptomatic trypanosoma cruzi-seropositive former blood donors. Circulation 127:1105–1115CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Chan J, Shiino K, Obonyo NG et al (2017) Left ventricular global strain analysis by two-dimensional speckle-tracking echocardiography: the learning curve. J Am Soc Echocardiogr 30:1081–1090CrossRefPubMed Chan J, Shiino K, Obonyo NG et al (2017) Left ventricular global strain analysis by two-dimensional speckle-tracking echocardiography: the learning curve. J Am Soc Echocardiogr 30:1081–1090CrossRefPubMed
9.
Zurück zum Zitat Barbosa MM, Costa Rocha MO, Vidigal DF et al (2014) Early detection of left ventricular contractility abnormalities by two-dimensional speckle tracking strain in Chagas’ disease. Echocardiography 31:623–630CrossRefPubMed Barbosa MM, Costa Rocha MO, Vidigal DF et al (2014) Early detection of left ventricular contractility abnormalities by two-dimensional speckle tracking strain in Chagas’ disease. Echocardiography 31:623–630CrossRefPubMed
10.
Zurück zum Zitat Garcia-Alvarez A, Sitges M, Regueiro A et al (2011) Myocardial deformation analysis in chagas heart disease with the use of speckle tracking echocardiography. J Cardiac Fail 17:1028–1034CrossRef Garcia-Alvarez A, Sitges M, Regueiro A et al (2011) Myocardial deformation analysis in chagas heart disease with the use of speckle tracking echocardiography. J Cardiac Fail 17:1028–1034CrossRef
12.
Zurück zum Zitat Santos Junior OR, Costa Rocha MO, Rodrigues de Almeida F et al (2019) Speckle tracking echocardiographic deformation indices in chagas and idiopathic dilated cardiomyopathy: Incremental prognostic value of longitudinal strain. PLoS ONE 14:e0221028CrossRefPubMedPubMedCentral Santos Junior OR, Costa Rocha MO, Rodrigues de Almeida F et al (2019) Speckle tracking echocardiographic deformation indices in chagas and idiopathic dilated cardiomyopathy: Incremental prognostic value of longitudinal strain. PLoS ONE 14:e0221028CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Cardoso CS, Sabino EC, Oliveira CD et al (2016) Longitudinal study of patients with chronic Chagas cardiomyopathy in brazil (sami-trop project): a cohort profile. BMJ Open 6:e011181CrossRefPubMedPubMedCentral Cardoso CS, Sabino EC, Oliveira CD et al (2016) Longitudinal study of patients with chronic Chagas cardiomyopathy in brazil (sami-trop project): a cohort profile. BMJ Open 6:e011181CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Marcolino MS, Palhares DM, Ferreira LR, Ribeiro AL (2015) Electrocardiogram and Chagas disease: a large population database of primary care patients. Glob Heart 10:167–172CrossRefPubMed Marcolino MS, Palhares DM, Ferreira LR, Ribeiro AL (2015) Electrocardiogram and Chagas disease: a large population database of primary care patients. Glob Heart 10:167–172CrossRefPubMed
16.
Zurück zum Zitat Denes P, Larson JC, Lloyd-Jones DM, Prineas RJ, Greenland P (2007) Major and minor ecg abnormalities in asymptomatic women and risk of cardiovascular events and mortality. JAMA 297:978–985CrossRefPubMed Denes P, Larson JC, Lloyd-Jones DM, Prineas RJ, Greenland P (2007) Major and minor ecg abnormalities in asymptomatic women and risk of cardiovascular events and mortality. JAMA 297:978–985CrossRefPubMed
17.
Zurück zum Zitat Ribeiro AL, Marcolino MS, Prineas RJ, Lima-Costa MF (2014) Electrocardiographic abnormalities in elderly Chagas disease patients: 10-year follow-up of the bambui cohort study of aging. J Am Heart Assoc 3:e000632CrossRefPubMedPubMedCentral Ribeiro AL, Marcolino MS, Prineas RJ, Lima-Costa MF (2014) Electrocardiographic abnormalities in elderly Chagas disease patients: 10-year follow-up of the bambui cohort study of aging. J Am Heart Assoc 3:e000632CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Rojas LZ, Glisic M, Pletsch-Borba L et al (2018) Electrocardiographic abnormalities in Chagas disease in the general population: a systematic review and meta-analysis. PLoS Negl Trop Dis 12:e0006567CrossRefPubMedPubMedCentral Rojas LZ, Glisic M, Pletsch-Borba L et al (2018) Electrocardiographic abnormalities in Chagas disease in the general population: a systematic review and meta-analysis. PLoS Negl Trop Dis 12:e0006567CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Lang RM, Badano LP, Mor-Avi V et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the american society of echocardiography and the european association of cardiovascular imaging. J Am Soc Echocardiogr 28(1–39):e14 Lang RM, Badano LP, Mor-Avi V et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the american society of echocardiography and the european association of cardiovascular imaging. J Am Soc Echocardiogr 28(1–39):e14
20.
Zurück zum Zitat Marwick TH, Leano RL, Brown J et al (2009) Myocardial strain measurement with 2-dimensional speckle-tracking echocardiography definition of normal range. JACC: Cardiovasc Imaging 2:80–84PubMed Marwick TH, Leano RL, Brown J et al (2009) Myocardial strain measurement with 2-dimensional speckle-tracking echocardiography definition of normal range. JACC: Cardiovasc Imaging 2:80–84PubMed
21.
Zurück zum Zitat Sun JP, Popović ZB, Greenberg NL et al (2004) Noninvasive quantification of regional myocardial function using doppler-derived velocity, displacement, strain rate, and strain in healthy volunteers: effects of aging. J Am Soc Echocardiogr 17:132–138CrossRefPubMed Sun JP, Popović ZB, Greenberg NL et al (2004) Noninvasive quantification of regional myocardial function using doppler-derived velocity, displacement, strain rate, and strain in healthy volunteers: effects of aging. J Am Soc Echocardiogr 17:132–138CrossRefPubMed
22.
Zurück zum Zitat Haugaa KH, Grenne BL, Eek CH et al (2013) Strain echocardiography improves risk prediction of ventricular arrhythmias after myocardial infarction. JACC: Cardiovasc Imaging 6:841–850PubMed Haugaa KH, Grenne BL, Eek CH et al (2013) Strain echocardiography improves risk prediction of ventricular arrhythmias after myocardial infarction. JACC: Cardiovasc Imaging 6:841–850PubMed
23.
Zurück zum Zitat Nascimento CA, Gomes VA, Silva SK et al (2013) Left atrial and left ventricular diastolic function in chronic Chagas disease. J Am Soc Echocardiogr 26:1424–1433CrossRefPubMed Nascimento CA, Gomes VA, Silva SK et al (2013) Left atrial and left ventricular diastolic function in chronic Chagas disease. J Am Soc Echocardiogr 26:1424–1433CrossRefPubMed
24.
Zurück zum Zitat Romano MMD, Moreira HT (2020) Early impairment of myocardial deformation assessed by regional speckle-tracking echocardiography in the indeterminate form of Chagas disease without fibrosis detected by cardiac magnetic resonance. PLoS Negl Trop Dis 14:e0008795CrossRefPubMedPubMedCentral Romano MMD, Moreira HT (2020) Early impairment of myocardial deformation assessed by regional speckle-tracking echocardiography in the indeterminate form of Chagas disease without fibrosis detected by cardiac magnetic resonance. PLoS Negl Trop Dis 14:e0008795CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Acquatella H, Asch FM, Barbosa MM et al (2018) Recommendations for multimodality cardiac imaging in patients with Chagas disease: a report from the american society of echocardiography in collaboration with the interamerican association of echocardiography (ecosiac) and the cardiovascular imaging department of the brazilian society of cardiology (dic-sbc). J Am Soc Echocardiogr 31:3–25CrossRefPubMed Acquatella H, Asch FM, Barbosa MM et al (2018) Recommendations for multimodality cardiac imaging in patients with Chagas disease: a report from the american society of echocardiography in collaboration with the interamerican association of echocardiography (ecosiac) and the cardiovascular imaging department of the brazilian society of cardiology (dic-sbc). J Am Soc Echocardiogr 31:3–25CrossRefPubMed
28.
Zurück zum Zitat Barbosa MM, Rocha MO, Botoni FA, Ribeiro AL, Nunes MC (2011) Is atrial function in chagas dilated cardiomyopathy more impaired than in idiopathic dilated cardiomyopathy? Eur J Echocardiogr 12:643–647CrossRefPubMed Barbosa MM, Rocha MO, Botoni FA, Ribeiro AL, Nunes MC (2011) Is atrial function in chagas dilated cardiomyopathy more impaired than in idiopathic dilated cardiomyopathy? Eur J Echocardiogr 12:643–647CrossRefPubMed
29.
Zurück zum Zitat Saraiva RM, Pacheco NP, Pereira TO et al (2020) Left atrial structure and function predictors of new-onset atrial fibrillation in patients with Chagas disease. J Am Soc Echocardiogr 33(1363–1374):e1361 Saraiva RM, Pacheco NP, Pereira TO et al (2020) Left atrial structure and function predictors of new-onset atrial fibrillation in patients with Chagas disease. J Am Soc Echocardiogr 33(1363–1374):e1361
30.
Zurück zum Zitat Costa MLe, Barreto S, Guerra H, Firmo J, Uchoa E, Vidigal P (2001) Ageing with trypanosoma cruzi infection in a community where the transmission has been interrupted: the bambuí health and ageing study (bhas). Int J Epidemiol 30:887–893CrossRef Costa MLe, Barreto S, Guerra H, Firmo J, Uchoa E, Vidigal P (2001) Ageing with trypanosoma cruzi infection in a community where the transmission has been interrupted: the bambuí health and ageing study (bhas). Int J Epidemiol 30:887–893CrossRef
31.
Zurück zum Zitat Martins-Melo FR, Ramos AN Jr, Alencar CH, Heukelbach J (2014) Prevalence of Chagas disease in brazil: a systematic review and meta-analysis. Acta Trop 130:167–174CrossRefPubMed Martins-Melo FR, Ramos AN Jr, Alencar CH, Heukelbach J (2014) Prevalence of Chagas disease in brazil: a systematic review and meta-analysis. Acta Trop 130:167–174CrossRefPubMed
33.
Zurück zum Zitat Pereira LDS, Freitas EC, Vasconcelos F et al (2015) Clinical and epidemiological profile of elderly patients with chagas disease followed between 2005–2013 by pharmaceutical care service in ceará state, northeastern brazil. Rev Inst Med Trop S Paulo 57:145–152CrossRefPubMedPubMedCentral Pereira LDS, Freitas EC, Vasconcelos F et al (2015) Clinical and epidemiological profile of elderly patients with chagas disease followed between 2005–2013 by pharmaceutical care service in ceará state, northeastern brazil. Rev Inst Med Trop S Paulo 57:145–152CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Kamiji MM, Oliveira RBd (2005) O perfil dos portadores de doença de chagas, com ênfase na forma digestiva, em hospital terciário de ribeirão preto, sp. Revis Soc Bras Med Trop 38:305–309CrossRef Kamiji MM, Oliveira RBd (2005) O perfil dos portadores de doença de chagas, com ênfase na forma digestiva, em hospital terciário de ribeirão preto, sp. Revis Soc Bras Med Trop 38:305–309CrossRef
35.
Zurück zum Zitat Oliveira F, Reis M, Teixeira P (2001) A cardiopatia chagásica em idosos necropsiados. Rev Soc Bras Med Trop 34:161–162 Oliveira F, Reis M, Teixeira P (2001) A cardiopatia chagásica em idosos necropsiados. Rev Soc Bras Med Trop 34:161–162
37.
Zurück zum Zitat Yingchoncharoen T, Agarwal S, Popović ZB, Marwick TH (2013) Normal ranges of left ventricular strain: a meta-analysis. J Am Soc Echocardiogr 26:185–191CrossRefPubMed Yingchoncharoen T, Agarwal S, Popović ZB, Marwick TH (2013) Normal ranges of left ventricular strain: a meta-analysis. J Am Soc Echocardiogr 26:185–191CrossRefPubMed
38.
Zurück zum Zitat Dalen H, Thorstensen A, Aase SA et al (2010) Segmental and global longitudinal strain and strain rate based on echocardiography of 1266 healthy individuals: the hunt study in norway. Eur J Echocardiogr 11:176–183PubMed Dalen H, Thorstensen A, Aase SA et al (2010) Segmental and global longitudinal strain and strain rate based on echocardiography of 1266 healthy individuals: the hunt study in norway. Eur J Echocardiogr 11:176–183PubMed
39.
Zurück zum Zitat Kim HL, Lim WH, Seo JB et al (2021) Clinical factors associated with reduced global longitudinal strain in subjects with normal left ventricular ejection fraction. Int J Cardiovasc Imaging 37:3225–3232CrossRefPubMed Kim HL, Lim WH, Seo JB et al (2021) Clinical factors associated with reduced global longitudinal strain in subjects with normal left ventricular ejection fraction. Int J Cardiovasc Imaging 37:3225–3232CrossRefPubMed
40.
Zurück zum Zitat Xu L, Huang X, Ma J et al (2017) Value of three-dimensional strain parameters for predicting left ventricular remodeling after ST-elevation myocardial infarction. Int J Cardiovasc Imaging 33:663–673CrossRefPubMed Xu L, Huang X, Ma J et al (2017) Value of three-dimensional strain parameters for predicting left ventricular remodeling after ST-elevation myocardial infarction. Int J Cardiovasc Imaging 33:663–673CrossRefPubMed
Metadaten
Titel
Prevalence and factors associated with impaired left ventricular global longitudinal strain in patients with Chagas disease: SaMi-Trop cohort study
verfasst von
Omar Ribeiro Santos Junior
Ester Cerdeira Sabino
Vinícius Tostes Carvalho
Bruno Oliveira de Figueiredo Brito
Lea Campos de Oliveira
Ariela Mota Ferreira
Marcelo Alves Maia
Nayana Flamini Arantes Gomes
Antonio Luiz P. Ribeiro
Maria Carmo P. Nunes
Publikationsdatum
04.07.2022
Verlag
Springer Netherlands
Erschienen in
The International Journal of Cardiovascular Imaging / Ausgabe 11/2022
Print ISSN: 1569-5794
Elektronische ISSN: 1875-8312
DOI
https://doi.org/10.1007/s10554-022-02640-w

Weitere Artikel der Ausgabe 11/2022

The International Journal of Cardiovascular Imaging 11/2022 Zur Ausgabe

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.